Evidence map›Paper›PMID 38536529›Full record

ArticleMikrochimica acta2024

Pioneering electrochemical detection unveils erdafitinib: a breakthrough in anticancer agent determination.

Merve Hatun Yildir, Asena Ayse Genc, Nevin Erk, Wiem Bouali, Nesrin Bugday, Sedat Yasar, Ozgur Duygulu

Open access · hybridAbstract read
In one paragraph

Article in Mikrochimica acta, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Superior Electrochemical Sensor Application of CoLangmuir : the ACS journal of surfaces and colloids · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Merve Hatun YildirFaculty of Pharmacy, Department of Analytical Chemistry, Ankara University, 06560, Ankara, Turkey. ecz.merveyildir@gmail.com.ORCID http://orcid.org/0009-0009-1199-506X
Asena Ayse GencFaculty of Pharmacy, Department of Analytical Chemistry, Ankara University, 06560, Ankara, Turkey.
Nevin ErkFaculty of Pharmacy, Department of Analytical Chemistry, Ankara University, 06560, Ankara, Turkey. erk@pharmacy.ankara.edu.tr.
Wiem BoualiFaculty of Pharmacy, Department of Analytical Chemistry, Ankara University, 06560, Ankara, Turkey.
Nesrin BugdayDepartment of Chemistry, İnonu University, 44280, Malatya, Turkey.
Sedat YasarDepartment of Chemistry, İnonu University, 44280, Malatya, Turkey.
Ozgur DuyguluTÜBİTAK Marmara Research Center, Materials Technologies, TÜBİTAK Gebze Campus, 41470, Gebze, Kocaeli, Turkey.
Ankara University · TRInonu University · TRTÜBİTAK Marmara Research Center · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The successful fabrication is reported of highly crystalline Co nanoparticles interconnected with zeolitic imidazolate framework (ZIF-12) -based amorphous porous carbon using the molten-salt-assisted approach utilizing NaCl. Single crystal diffractometers (XRD), and X-ray photoelectron spectroscopy (XPS) analyses confirm the codoped amorphous carbon structure. Crystallite size was calculated by Scherrer (34 nm) and Williamson-Hall models (42 nm). The magnetic properties of NPCS (N-doped porous carbon sheet) were studied using a vibrating sample magnetometer (VSM). The NPCS has a magnetic saturation (Ms) value of 1.85 emu/g. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) analyses show that Co/Co

Indexed as

Antineoplastic AgentsCobaltOxidesPyrazolesQuinoxalinesSodium ChlorideCarbonReproducibility of ResultsAntineoplastic AgentsCarbonCobaltcobalt tetraoxideerdafitinibOxidesPyrazolesQuinoxalinesSodium ChlorideElectrochemical sensorErdafitinibModified electrodeMolten saltsPorous carbonVoltammetry

Identifiers

PMID38536529
PMCPMC10973028
OpenAlexW4393226333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.